z-logo
open-access-imgOpen Access
Importance of mir-411-5p in colorectal cancer
Author(s) -
Alavieh Fateh,
Mohammad Ali Hosseinpour Feizi,
Reza Safaralizadeh,
Shirin Azarbarzin
Publication year - 2018
Publication title -
journal of biological research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 6
eISSN - 2284-0230
pISSN - 1826-8838
DOI - 10.4081/jbr.2017.6511
Subject(s) - colorectal cancer , microrna , carcinogenesis , cancer , receiver operating characteristic , cancer research , reverse transcription polymerase chain reaction , real time polymerase chain reaction , oncology , biology , medicine , messenger rna , gene , genetics
The abnormal expression of microRNAs (miRNAs) plays a key role in colorectal cancer (CRC). The present study attempted to identify the potential miRNA biomarkers of CRC due to the important role of microRNAs within the DLK1-DIO3 genomic region, especially the role of mir-411-5p in other cancers. This prospective study characterized the contribution of mir-411-5p to CRC tumorigenesis. The Real-time quantitative reverse-transcription –polymerase chain reaction was used to examine miR-411-5p expression levels prospectively in 40 pairs of samples of CRC tissues and adjacent noncancerous tissues (>2 cm from cancer tissue). Also, the relationship between miR-411-5p expression levels and clinicopathological characteristics was explored. The capability of miR-411-5p to function as a tumor marker in CRC was also examined. MiR-411-5p was significantly downregulated in a group of CRC samples compared with matched noncancerous tissues. A receiver operating characteristic (ROC) curve also showed ROC area of 68% for miR-411-5p (P value=0.006) with 70% and 65% sensitivity and specificity, respectively. According to the survey results, miR-411-5p might be considered as a tumor marker in CRC and it might be a promising therapeutic option which may help prevent CRC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here